5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The Aptamers Market is segmented by Type (Nucleic Acid and Peptide), Application, and Geography.
2018 - 2026
Fastest Growing Market:
Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are some of the key driving factors responsible for the growth of the aptamers market.
Aptamers are short, single-stranded DNA or RNA (ssDNA or ssRNA) molecules, which can selectively bind to a specific target, including peptides, proteins, small molecules, carbohydrates, toxins, and even live cells. Aptamers assume various shapes, owing to their tendency to form helices or single-stranded loops. These molecules are extremely versatile and are used to bind targets with high specificity and selectivity.
|Research and Development|
Report scope can be customized per your requirements. Click here.
Appropriate diagnosis is the most crucial factor for the treatment of diseases, especially viral diseases. Over the past few years, aptamer technology has observed a significant rise in its demand and usage all across the world. It has been used in a wide range of diagnostic as well as therapeutic applications; several strategies are currently being explored, in a definitive or conclusive way, using aptamers against virus proteins. From a diagnostic point of view, aptamers are presently being designed as a bio-recognition element in a variety of diagnostic systems in order to detect viral proteins, either in the blood (serum or plasma) or in the infected cells.
To understand key trends, Download Sample Report
The North American region dominates the aptamers market due to rapid technological advancements and high investment and funding to support the development of aptamers. The United States has been the hub of all major R&D activities related to aptamers. The first aptamer therapeutic product ‘’Macugen’’ was approved in 2004 by the US FDA (United States Food and Drugs Administration).
In the country, R&D happens to be the most active area of application of aptamers. A significant proportion of demand is seen in research applications, which is also responsible for generating revenues in the market. Furthermore, the growing acceptance of personalized medicine is also one of the major factors driving the growth of the market. Aptamers have evolved rapidly in the past ten years, and aptamers have targeted a range of molecules involved in tumor progression and metastasis, present at different sites.
To understand geography trends, Download Sample Report.
The aptamers market is highly competitive and consists of a number of major players. Companies, like AM Biotechnologies LLC, Aptagen LLC, Aptamer Sciences Inc., Aptamer Group, Aptus Biotech S.L., Base Pair Biotechnologies Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies Inc., and Vivonics Inc., among others, hold the substantial share in the aptamers market.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advantages of Aptamers Compared to Antibodies
4.2.2 Advancements in the Field of Aptamer Technologies
4.2.3 Growing Investment by Major Companies
4.3 Market Restraints
4.3.1 Unfavorable Pharmacokinetic Properties of Aptamers
4.3.2 Issues Regarding Aptamer Development
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1.1 Nucleic Acid
5.2.3 Research and Development
5.2.4 Other Applications
5.3.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle-East and Africa
5.3.5 South America
188.8.131.52 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AM Biotechnologies LLC
6.1.2 Aptagen LLC
6.1.3 Aptamer Sciences Inc.
6.1.4 Aptamer Group
6.1.5 Aptus Biotech S.L.
6.1.6 Base Pair Biotechnologies Inc.
6.1.7 NOXXON Pharma
6.1.8 SomaLogic Inc.
6.1.9 Baush Health
6.1.10 Maravai Lifesciences (Trilink Biotechnologies)
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments